Gefässchirurgie

, Volume 15, Issue 5, pp 340–344 | Cite as

Tiefe Venenthrombose bei junger Frau mit heterozygoter Faktor-V-Leiden-Mutation

Fragen aus der Praxis

Literatur

  1. 1.
    Beyth RJ, Quinn LM, Landefeld CS (1998) Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105:91–99CrossRefPubMedGoogle Scholar
  2. 2.
    Eichinger S, Minar E, Bialonczyk C et al (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290:1071–1074CrossRefPubMedGoogle Scholar
  3. 3.
    Encke A, Haas S, Sauerland S et al (2009) S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). VASA 38(Suppl 76):1–131CrossRefGoogle Scholar
  4. 4.
    Kearon C, Ginsberg JS, Kovacs MJ et al (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349:631–639CrossRefPubMedGoogle Scholar
  5. 5.
    Kearon C, Kahn SR, Agnelli G et al (2008) Antithrombotic therapy for venous thromboembolic disease. Chest 133:454S–545SCrossRefPubMedGoogle Scholar
  6. 6.
    Levine MN, Raskob G, Beyth RJ et al (2004) Hemorrhagic complications of anticoagulant treatment. Chest 126:287S–310SCrossRefPubMedGoogle Scholar
  7. 7.
    Lidegaard O, Lokkegaard E, Svendsen AL, Agger C (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 339:b2890CrossRefPubMedGoogle Scholar
  8. 8.
    Lindmarker P, Schulman S, Sten-Linder M et al (1999) The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. Thromb Haemost 81:684–689PubMedGoogle Scholar
  9. 9.
    Palareti G, Legnani C, Cosmi B et al (2003) Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 108:313–318CrossRefPubMedGoogle Scholar
  10. 10.
    Ridker PM, Goldhaber SZ, Danielson E et al (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348:1425–1434CrossRefPubMedGoogle Scholar
  11. 11.
    Hylckama V van, Helmerhorst FM, Vandenbroucke JP et al (2009) The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 339:b2921CrossRefGoogle Scholar
  12. 12.
    Zotz RB, Sucker C, Gerhardt A (2009) Klinische Relevanz der Thrombophilie-Diagnostik. Gefaessmedizin.net 5:4–23Google Scholar
  13. 13.
    Zotz RB, Gerhardt A, Segendorf H, Scharf RE (2001) Significance of hereditary risk factors in patients with spontaneous recurrent thromboembolism [abstract]. Angiology 20:58–59Google Scholar
  14. 14.
    Zotz RB, Sucker C, Gerhardt A (2008) Thrombophilia in pregnancy venous thromboembolism, fetal loss, preeclampsia, intrauterine growth restriction. Hamostaseologie 28:455–464PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Centrum für Blutgerinnungsstörungen und Transfusionsmedizin (CBT)DüsseldorfDeutschland
  2. 2.Blutgerinnung UlmUlmDeutschland
  3. 3.LaboMed Gerinnungszentrum BerlinBerlinDeutschland

Personalised recommendations